Small-molecule probes from bench to bedside: advancing molecular analysis of drug–target interactions toward precision medicine
Over the past decade, remarkable advances have been witnessed in the development of
small-molecule probes. These molecular tools have been widely applied for interrogating …
small-molecule probes. These molecular tools have been widely applied for interrogating …
Deubiquitylases from genes to organism
Ubiquitylation is a major posttranslational modification that controls most complex aspects of
cell physiology. It is reversed through the action of a large family of deubiquitylating …
cell physiology. It is reversed through the action of a large family of deubiquitylating …
Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction
P Bishop, D Rocca, JM Henley - Biochemical Journal, 2016 - portlandpress.com
Ubiquitin C-terminal hydrolase L1 (UCH-L1) is an extremely abundant protein in the brain
where, remarkably, it is estimated to make up 1–5% of total neuronal protein. Although it …
where, remarkably, it is estimated to make up 1–5% of total neuronal protein. Although it …
Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes, and pathways
M Synofzik, R Schüle - Movement Disorders, 2017 - Wiley Online Library
Autosomal‐dominant spinocerebellar ataxias, autosomal‐recessive spinocerebellar ataxias,
and hereditary spastic paraplegias have traditionally been designated in separate …
and hereditary spastic paraplegias have traditionally been designated in separate …
Insights into clinical, genetic, and pathological aspects of hereditary spastic paraplegias: a comprehensive overview
LEO Elsayed, IZ Eltazi, AE Ahmed… - Frontiers in Molecular …, 2021 - frontiersin.org
Hereditary spastic paraplegias (HSP) are a heterogeneous group of motor
neurodegenerative disorders that have the core clinical presentation of pyramidal syndrome …
neurodegenerative disorders that have the core clinical presentation of pyramidal syndrome …
Structural basis for specific inhibition of the deubiquitinase UCHL1
C Grethe, M Schmidt, GM Kipka, R O'Dea… - Nature …, 2022 - nature.com
Ubiquitination regulates protein homeostasis and is tightly controlled by deubiquitinases
(DUBs). Loss of the DUB UCHL1 leads to neurodegeneration, and its dysregulation …
(DUBs). Loss of the DUB UCHL1 leads to neurodegeneration, and its dysregulation …
The classification of autosomal recessive cerebellar ataxias: a consensus statement from the society for research on the cerebellum and ataxias task force
M Beaudin, A Matilla-Dueñas, BW Soong, JL Pedroso… - The Cerebellum, 2019 - Springer
There is currently no accepted classification of autosomal recessive cerebellar ataxias, a
group of disorders characterized by important genetic heterogeneity and complex …
group of disorders characterized by important genetic heterogeneity and complex …
Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury
Z Mi, SH Graham - Ageing research reviews, 2023 - Elsevier
UCHL1 is a multifunctional protein expressed at high concentrations in neurons in the brain
and spinal cord. UCHL1 plays important roles in regulating the level of cellular free ubiquitin …
and spinal cord. UCHL1 plays important roles in regulating the level of cellular free ubiquitin …
Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review
MJ Millan - Progress in neurobiology, 2017 - Elsevier
The human genome encodes a vast repertoire of protein non-coding RNAs (ncRNA), some
specific to the brain. MicroRNAs, which interfere with the translation of target mRNAs, are of …
specific to the brain. MicroRNAs, which interfere with the translation of target mRNAs, are of …
Loss of UCHL1 rescues the defects related to Parkinson's disease by suppressing glycolysis
The role of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1; also called PARK5) in the
pathogenesis of Parkinson's disease (PD) has been controversial. Here, we find that the loss …
pathogenesis of Parkinson's disease (PD) has been controversial. Here, we find that the loss …